Composition for the prevention, treatment, or improvement of viral infectious diseases, comprising a complex of an ER stress inhibitor and a reactive oxygen species scavenger as active ingredients

Quasi-universal antiviral composition that counteracts the oxidative stress mechanism

This technology presents a composition for the prevention, treatment, or improvement of viral infectious diseases, which includes a complex of an ER stress inhibitor and a reactive oxygen species scavenger as its active ingredients.

Existing vaccines are specific to particular viruses, necessitating new development with every emergence of novel viruses or mutations.

This technology works by counteracting the mechanism through which viruses proliferate by inducing oxidative damage to host cells. As it can inhibit the proliferation of most viruses regardless of their type or mutation, it can be utilized as a quasi-universal infection inhibitor/therapeutic agent and a disease control adjuvant.

‍

‍

Key Features:

• Complex formulation of an ER stress inhibitor and a reactive oxygen species scavenger
• Safety for human application ensured by using verified safe components
• Quasi-universal antiviral effect regardless of virus type or mutation
• Applicable as a preventive agent or adjuvant for novel virus outbreaks